Why invest in Hofseth BioCare?
A strong ESG-profile, and patented processes coupled with world class R&D with diversified pipelines including research programs on asthma, COVID-19 and gastro
Ticker:
HBC
Last updated:
02.08.2021 16:25
Latest
7.82 NOK
Change
-0.06
Change (%)
-0.76
Share information
IR contact
News
Reports
Governance
LATEST REPORT
Annual Report
Download our latest report, or view all quarterly and yearly reports in the archives.
NEXT UP
Financial calendar
Half-yearly Report
27.08.2021
Quarterly Report Q3
05.11.2021
Quarterly Report Q4
04.02.2022
Investor presentation
Download our latest investor presentation in PDF-format for a even deeper insight into our current ongoing business and future potential.
Download presentation
Stock exchange notices
View all notices
Contact investor relations
